Health
Behind R.F.K. Jr.’s Vow to ‘Follow the Science’ on Vaccines
Robert F. Kennedy Jr. spent the first day of his back-to-back confirmation hearings deftly avoiding questions about his views on vaccines. On the second day, when a prominent Republican senator insisted there was no link between vaccines and autism, Mr. Kennedy shot back that a new study “showed the opposite.”
“I just want to follow the science,” Mr. Kennedy declared.
Following the science has been a familiar refrain for Mr. Kennedy, whose confirmation as health secretary appears all but assured in a vote expected Thursday. But the exchange in the Senate raises questions about just what type of science Mr. Kennedy is consulting. It foreshadows how, if confirmed, Mr. Kennedy could continue to sow doubts about vaccines.
Academics have pounced on the study that Mr. Kennedy cited during the hearing, shredding it as methodologically faulty and biased. The study emanated from a network of vaccine skeptics who share some of Mr. Kennedy’s views — an ecosystem that includes the author of the study, the editor of the journal that published it and the advocacy group that financed it.
“We authors were delighted and honored that R.F.K. Jr. referred to our work in his confirmation hearing,” the study’s lead author, Anthony Mawson, said in an email. A spokeswoman for Mr. Kennedy did not respond to a request for comment.
Dr. Mawson, an epidemiologist, said he first met Mr. Kennedy at an autism conference in 2017. Mr. Kennedy cites Dr. Mawson’s research 33 times in his 2023 book, “Vax-Unvax: Let the Science Speak.”
His study was rejected “without explanation” by several mainstream medical journals, Dr. Mawson said. So he turned for advice to Andrew Wakefield, the author of the 1998 study, now retracted, that sparked the initial furor over vaccines and autism. Mr. Wakefield encouraged him to submit the study to a new journal called Science, Public Health Policy and the Law.
That publication is led by some notable vaccine critics, including three who headlined a Washington rally in 2022 with Mr. Kennedy to protest Covid vaccine mandates.
As the nation’s health secretary, Mr. Kennedy “would have wide powers to advance his favored research studies, publications, or scientific data,” according to Lawrence O. Gostin, a public health law expert at Georgetown University. Mr. Kennedy’s critics fear that the public will have neither the time nor the training to sort through a war that seems to pit one study against another, and that the result will be a rapid decline in confidence in vaccines.
“The Mawson paper epitomizes Kennedy’s consistent inability to distinguish junk science from reliable information,” said Dr. John P. Moore, professor of microbiology and immunology at Weill Cornell Medical College, who said that study and some of the others Mr. Kennedy has cited in the past are published by “fringe journals.”
Mr. Kennedy has said that he is not anti-vaccine, but rather in favor of vaccine safety.
“I support the measles vaccine. I support the polio vaccine,” Mr. Kennedy said on the first day of his confirmation hearings. “I will do nothing as H.H.S. secretary that makes it difficult or discourages people from taking it.”
Mr. Kennedy’s insistence that more research is necessary when it comes to vaccine safety has drawn support from some Republicans, who say they welcome his skepticism.
“I don’t understand why my colleagues all of sudden say we can’t question science,” Senator Markwayne Mullin, Republican of Oklahoma, said during one of Mr. Kennedy’s hearings. He added, “When you start looking at the rise of autism, why wouldn’t we be looking at everything?”
But Michael T. Osterholm, an epidemiologist at the University of Minnesota who has advised administrations of both parties, said Mr. Kennedy’s demands for additional data go too far when they concern vaccines and autism. Mainstream scientists say the issue is settled.
“That’s the equivalent of me saying until Newton comes back and shows me that apple falling from the tree, I do not believe gravity exists,” Dr. Osterholm said.
Doctors who have examined the way Mr. Kennedy uses scientific research say he also has a tendency to cherry-pick particular findings from prominent researchers, as he did during a podcast in 2022.
During that appearance, he cited a study published in the journal Pediatrics in 2000 to suggest that improvements in sanitation and hygiene — and not vaccines — fueled a drop in deaths from infectious diseases during the first half of the 20th century. That is true. But Mr. Kennedy failed to note that the study also reported that vaccines introduced in the second half of the 20th century had “virtually eliminated” deaths from diseases including polio and measles.
During one of his confirmation hearings, Mr. Kennedy cited work by a well-known vaccine scientist, Dr. Gregory Poland, to suggest Black people should follow a different vaccine schedule because they needed fewer antigens, the vaccine components that provoke an immune response.
Dr. Poland did not respond to requests for comment. But he told National Public Radio that his work did not support Mr. Kennedy’s assertion.
Mr. Kennedy and Dr. Mawson have long aired similar concerns about vaccines.
In an appearance before the Mississippi legislature in 2009, Dr. Mawson called for more vaccine safety research and “a more flexible approach to vaccination requirements for school attendance.” In a 2011 lawsuit, Dr. Mawson said the testimony had cost him his job as an epidemiologist at the University of Mississippi Medical Center.
In 2017, Dr. Mawson published a pilot study comparing vaccinated to unvaccinated children.
The study relied on a survey of parents who home-schooled their children and found higher rates of autism among vaccinated children, compared with those who had not been vaccinated. The study was funded in part by Generation Rescue, a nonprofit associated with Jenny McCarthy, a television personality who has promoted claims of a link between vaccines and autism.
Dr. Mawson by that time had established the Chalfont Research Institute, a charity that operates out of his home in Jackson, Miss. The institute reported revenue of just $57 in 2021, the most recent figures available.
In 2019, it received charitable contributions of $160,000, tax records show. The bulk of that money, $150,000, came from the National Vaccine Information Center, a group whose mission includes supporting research on “vaccine-associated deaths, injuries and chronic illness.”
Like Mr. Kennedy, the group’s president and co-founder, Barbara Loe Fisher, has long called for research comparing “total health outcomes” including the risk of autism, in vaccinated and unvaccinated children. When Dr. Mawson approached her group with a proposal, she said, the center reviewed his pilot study of 2017, approved his plan and provided $150,000 in funding.
That money paid for the paper Mr. Kennedy cited at the hearing, during an exchange with Senator Bill Cassidy, Republican of Louisiana and a doctor.
The journal that published the study, Science, Public Health Policy and the Law, advertises itself as peer-reviewed, meaning its research is evaluated by anonymous independent experts before publication. Dr. Mawson said his paper had undergone review by two such experts.
Some people associated with the journal are also associated with Mr. Kennedy.
James Lyons-Weiler, the journal’s editor in chief, described himself as a longtime ally of Mr. Kennedy’s in a yearslong “fight across 20 states” for vaccine exemptions.
“Honored to call him my friend,” he wrote on social media last year.
The journal’s editorial board includes the chief executive and the chief scientific officer of Children’s Health Defense, the nonprofit that Mr. Kennedy led until he began his presidential campaign in 2023.
The board also includes members who sell products or services for people who are concerned about vaccines. One of its editorial board members offers $2,350 telehealth appointments for “post-vaccine syndrome.” Another sells $90 “spike detox” supplements marketed for “vaccine injury syndrome” that is meant to get “you back to that pre-Covid feeling.”
The study by Dr. Mawson that Mr. Kennedy cited at the hearing focused on about 47,000 children enrolled in Florida Medicaid from 1999 to 2011 and looked at billing data to determine their vaccination status.
The study found very few billing records for unvaccinated children with autism — eight who were born prematurely and 54 overall. It concluded that vaccination was significantly associated with higher rates of neurodevelopmental disorders, including autism, particularly in infants who were born prematurely.
By contrast, large-scale studies in respected medical journals, including an analysis of five studies involving more than 1.2 million children, have found no association between vaccines and autism.
But even as Dr. Mawson’s research took shape, problems emerged. The paper notes that researchers lost access to the database they used to perform the study. Dr. Alex Morozov, an expert on clinical trial design who met with Dr. Mawson to discuss the study, said he viewed that as a red flag.
Dr. Morozov also said the study had a “fundamental flaw”: It failed to account for the possibility that vaccinated children might have more encounters with the medical system than unvaccinated children, whose illnesses would not be captured by billing data.
The study also failed to account for factors like family history of autism, the child’s gender (boys are diagnosed with higher rates of autism than girls) or the possibility that children might have been vaccinated outside the Florida Medicaid system, said Bertha Hidalgo, an associate professor of epidemiology at the University of Alabama at Birmingham.
Dr. Mawson strongly defended the work, noting that the study “carefully documents both its strengths and limitations,” but contending that critics focused only on the limitations. “Nevertheless,” he said, “further research is needed to replicate the findings and to unravel the mechanisms involved.”
At the Senate hearing, Mr. Cassidy pressed Mr. Kennedy to accept that the vaccines and autism debate was settled. He reminded Mr. Kennedy that he had been shown the study of 1.2 million children that found no link between the two.
“I’m a doc, trying to understand,” Mr. Cassidy said, adding, “Convince me that you will become the public health advocate, but not just churn old information so that there’s never a conclusion.”
To that, Mr. Kennedy replied, “I’m going to be an advocate for strong science. You show me those scientific studies, and you and I can meet about it. And there are other studies as well. I’d love to show those to you.”
Health
Hormone therapy boosts weight loss drug results by 35% in women, study finds
NEWYou can now listen to Fox News articles!
For women struggling with weight gain after menopause, a new study suggests that adding hormone therapy to a popular obesity drug may lead to greater weight loss.
Postmenopausal women lost about 35% more weight when using menopausal hormone therapy alongside tirzepatide — a GLP-1-based, Food and Drug Administration-approved drug for the overweight and obese — compared to those taking the drug alone, according to a Mayo Clinic study.
The findings, published in February in The Lancet Obstetrics, Gynaecology, & Women’s Health, highlight a possible new strategy for addressing weight gain after menopause, when hormonal shifts can increase the risk of obesity, cardiovascular disease and Type 2 diabetes.
STOPPING OZEMPIC? NEW STUDY REVEALS SURPRISING WEIGHT REGAIN RESULTS AFTER GLP-1S
“This study provides important insights for developing more effective and personalized strategies for managing cardiometabolic risk in postmenopausal women,” Dr. Regina Castaneda, the study’s first author, said in a statement.
A new study found that postmenopausal women lost more weight when combining hormone therapy with a GLP-1-based drug. (iStock)
Researchers analyzed 120 postmenopausal women who were overweight or obese who took tirzepatide for at least 12 months, including 40 who also used hormone therapy and 80 who did not.
Hormone therapy is commonly used to treat menopause symptoms like hot flashes and night sweats, while tirzepatide helps regulate appetite and blood sugar.
WEIGHT LOSS MEDICATIONS COULD IMPACT SEXUAL HEALTH IN UNEXPECTED WAYS
Women in the hormone therapy group lost an average of 19.2% of their body weight, compared to 14.0% in the non-hormone group — about 35% greater relative weight loss — with more women reaching significant weight-loss thresholds, according to the study.
Despite the results, researchers emphasized that the study was observational and cannot prove cause and effect.
Hormonal changes after menopause can increase weight gain and health risks. (iStock)
“Because this was not a randomized trial, we cannot say hormone therapy caused additional weight loss,” said Dr. Maria Daniela Hurtado Andrade, an endocrinologist at Mayo Clinic and senior author of the study.
TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ
Outside experts agree that the findings must be interpreted cautiously.
“As with all observational studies, we need to interpret this study with a grain of salt,” Dr. Gillian Goddard, a board-certified endocrinologist, told Fox News Digital.
Goddard, who is also an adjunct assistant professor of medicine at the NYU Grossman School of Medicine, noted that the findings show a link but do not prove that hormone therapy, which usually includes estrogen, directly caused the additional weight loss.
CLICK HERE FOR MORE HEALTH STORIES
“There may be important differences between the two groups,” she added. “For one thing, the group taking estrogen may be healthier than the groups that didn’t take estrogen. … Healthier people are more likely to eat a healthy diet and exercise in addition to taking tirzepatide. That could lead to more weight loss.”
Tirzepatide, a GLP-1-based drug, may be more effective for weight loss when paired with hormone therapy, according to researchers. (iStock)
Symptom relief from the therapy may have also improved sleep and well-being, making it easier for the group to maintain diet and exercise routines, Hurtado Andrade noted.
Researchers also pointed to a possible biological explanation. Preclinical data suggest estrogen may enhance the appetite-suppressing effects of GLP-1-based medications like tirzepatide, according to the study.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
Goddard said that theory is plausible but unproven.
Hormone therapy may ease menopause symptoms and help women stay on track with diet and exercise. (iStock)
“The other possibility is that estrogen interacts with tirzepatide in some way that makes it more potent,” she said. “We will need randomized studies to get a better handle on that.”
As for safety, experts say using the two together appears safe for most women. However, hormone therapy is not recommended for all patients, especially those with a history of certain cancers, blood clots or other underlying health risks, according to the Mayo Clinic.
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
Researchers say future randomized trials will aim to confirm the findings and explore whether the combination also improves broader cardiometabolic health outcomes, according to the study.
Experts say more research is needed to confirm whether hormone therapy directly boosts weight loss results with GLP-1 drugs. (iStock)
“If confirmed, this work could speed the development and adoption of new, evidence-based strategies to reduce this risk for millions of postmenopausal women navigating this life stage,” Hurtado Andrade said.
Fox News Digital has reached out to the study authors for comment.
Health
The Best Belly Fat-Burning Foods That Shrink Your Waist up to 3X Faster
Use left and right arrow keys to navigate between menu items.
Use escape to exit the menu.
Sign Up
Create a free account to access exclusive content, play games, solve puzzles, test your pop-culture knowledge and receive special offers.
Already have an account? Login
Health
Most Americans are doing one nightly activity that’s wrecking their sleep, expert says
NEWYou can now listen to Fox News articles!
If you’re not sleeping well, there could be a variety of reasons, but one habit stands out as the biggest culprit.
Dr. Wendy Troxel, a licensed clinical psychologist and senior behavioral scientist at RAND based in Utah, revealed that phone use at night is the activity that is most likely to have a negative effect on slumber.
“Most people are aware of this, but probably the No. 1 habit that’s contributing to interrupted sleep and poor-quality sleep in Americans is the use of phones at night, particularly in bed,” she said in an interview with Fox News Digital.
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
“About 90% of Americans are using their phones in bed, and as much as I would like to tell everybody to remove the phone entirely from the bedroom, I realize that ship has probably sailed by now.”
About 90% of Americans use their phones in bed, the sleep expert said. (iStock)
This disruption is driven by both blue light exposure and the stimulating content on phones, according to Troxel.
“There is blue light emitted from our devices, and blue light can suppress the hormone melatonin, which is the hormone of darkness.”
CLICK HERE FOR MORE HEALTH STORIES
“But it’s not just the blue light that is causing sleep disruptions from our phones. It’s really the stimulating content that we’re consuming … (on) social media, which is designed to be addictive, so that you can’t put that phone down,” she added.
The combination of blue light and stimulating content keeps the mind alert and interrupts quality sleep. (iStock)
This content is also “very emotionally activating,” Troxel noted, which is “antithetical to the state we want to be in as we approach sleep.”
To counteract attachment to phones, the sleep expert recommends setting a boundary with one simple rule.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
“I recommend that you try to keep your phone more than arms’ distance away from you while in bed,” she advised. “And set a rule for yourself. If you’re going to use the phone, don’t do it in bed. In fact, make your feet be on the floor if you’re going to use that phone.”
“I recommend that you try to keep your phone more than arms’ distance away from you while in bed,” the sleep expert recommended. (iStock)
Setting this boundary creates “behavioral friction,” according to Troxel.
“As a clinical psychologist, I work with people to help them … break habits that aren’t serving them,” she said. “Having that little bit of behavioral friction makes the habit of immediately grabbing for the phone and scrolling while in bed a little more difficult.
TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ
“And when that automatic behavior is a little more difficult, it’s less likely to occur.”
-
Sports1 week agoIOC addresses execution of 19-year-old Iranian wrestler Saleh Mohammadi
-
New Mexico6 days agoClovis shooting leaves one dead, four injured
-
Tennessee5 days agoTennessee Police Investigating Alleged Assault Involving ‘Reacher’ Star Alan Ritchson
-
Technology7 days agoYouTube job scam text: How to spot it fast
-
Minneapolis, MN3 days agoBoy who shielded classmate during school shooting receives Medal of Honor
-
Texas1 week agoHow to buy Houston vs. Texas A&M 2026 March Madness tickets
-
Science1 week agoRecord Heat Meets a Major Snow Drought Across the West
-
Politics1 week agoSchumer gambit fails as DHS shutdown hits 36 days and airport lines grow